Literature DB >> 23399656

The multifaceted role of mTORC1 in the control of lipid metabolism.

Stéphane J H Ricoult1, Brendan D Manning.   

Abstract

The mechanistic target of rapamycin is a protein kinase that, as part of the mechanistic target of rapamycin complex 1 (mTORC1), senses both local nutrients and, through insulin signalling, systemic nutrients to control a myriad of cellular processes. Although roles for mTORC1 in promoting protein synthesis and inhibiting autophagy in response to nutrients have been well established, it is emerging as a central regulator of lipid homeostasis. Here, we discuss the growing genetic and pharmacological evidence demonstrating the functional importance of its signalling in controlling mammalian lipid metabolism, including lipid synthesis, oxidation, transport, storage and lipolysis, as well as adipocyte differentiation and function. Defining the role of mTORC1 signalling in these metabolic processes is crucial to understanding the pathophysiology of obesity and its relationship to complex diseases, including diabetes and cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23399656      PMCID: PMC3589096          DOI: 10.1038/embor.2013.5

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  88 in total

1.  Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.

Authors:  Asami Hagiwara; Marion Cornu; Nadine Cybulski; Pazit Polak; Charles Betz; Francesca Trapani; Luigi Terracciano; Markus H Heim; Markus A Rüegg; Michael N Hall
Journal:  Cell Metab       Date:  2012-04-19       Impact factor: 27.287

Review 2.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

3.  Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c.

Authors:  Min Wan; Karla F Leavens; Danish Saleh; Rachael M Easton; David A Guertin; Timothy R Peterson; Klaus H Kaestner; David M Sabatini; Morris J Birnbaum
Journal:  Cell Metab       Date:  2011-10-05       Impact factor: 27.287

4.  mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway.

Authors:  Timothy R Peterson; Shomit S Sengupta; Thurl E Harris; Anne E Carmack; Seong A Kang; Eric Balderas; David A Guertin; Katherine L Madden; Anne E Carpenter; Brian N Finck; David M Sabatini
Journal:  Cell       Date:  2011-08-05       Impact factor: 41.582

5.  Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice.

Authors:  Ding Ai; Chiyuan Chen; Seongah Han; Anjali Ganda; Andrew J Murphy; Rebecca Haeusler; Edward Thorp; Domenico Accili; Jay D Horton; Alan R Tall
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

6.  Role of S6K1 in regulation of SREBP1c expression in the liver.

Authors:  Shuying Li; Wataru Ogawa; Aki Emi; Kumiko Hayashi; Yoko Senga; Kazuhiro Nomura; Kenta Hara; Demin Yu; Masato Kasuga
Journal:  Biochem Biophys Res Commun       Date:  2011-07-22       Impact factor: 3.575

Review 7.  SREBPs: metabolic integrators in physiology and metabolism.

Authors:  Tae-Il Jeon; Timothy F Osborne
Journal:  Trends Endocrinol Metab       Date:  2011-12-07       Impact factor: 12.015

8.  Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity.

Authors:  Dudley W Lamming; Lan Ye; Pekka Katajisto; Marcus D Goncalves; Maki Saitoh; Deanna M Stevens; James G Davis; Adam B Salmon; Arlan Richardson; Rexford S Ahima; David A Guertin; David M Sabatini; Joseph A Baur
Journal:  Science       Date:  2012-03-30       Impact factor: 47.728

9.  The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile.

Authors:  Beatrice T Wang; Gregory S Ducker; Andrea J Barczak; Rebecca Barbeau; David J Erle; Kevan M Shokat
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

Review 10.  FAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling.

Authors:  Rudolf Zechner; Robert Zimmermann; Thomas O Eichmann; Sepp D Kohlwein; Guenter Haemmerle; Achim Lass; Frank Madeo
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

View more
  87 in total

1.  Alpha-lipoic acid supplementation reduces mTORC1 signaling in skeletal muscle from high fat fed, obese Zucker rats.

Authors:  Zhuyun Li; Cory M Dungan; Bradley Carrier; Todd C Rideout; David L Williamson
Journal:  Lipids       Date:  2014-11-01       Impact factor: 1.880

2.  Target of rapamycin (TOR) plays a critical role in triacylglycerol accumulation in microalgae.

Authors:  Sousuke Imamura; Yasuko Kawase; Ikki Kobayashi; Toshiyuki Sone; Atsuko Era; Shin-Ya Miyagishima; Mie Shimojima; Hiroyuki Ohta; Kan Tanaka
Journal:  Plant Mol Biol       Date:  2015-09-08       Impact factor: 4.076

Review 3.  mTOR function and therapeutic targeting in breast cancer.

Authors:  Stephen H Hare; Amanda J Harvey
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

4.  Obesity Notches up fatty liver.

Authors:  Michael P Czech
Journal:  Nat Med       Date:  2013-08       Impact factor: 53.440

Review 5.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

6.  Middle-aged overweight South Asian men exhibit a different metabolic adaptation to short-term energy restriction compared with Europeans.

Authors:  Leontine E H Bakker; Bruno Guigas; Linda D van Schinkel; Gerard C M van der Zon; Trea C M Streefland; Jan B van Klinken; Jacqueline T Jonker; Hildo J Lamb; Johannes W A Smit; Hanno Pijl; A Edo Meinders; Ingrid M Jazet
Journal:  Diabetologia       Date:  2014-10-15       Impact factor: 10.122

7.  Egr1 mediates the effect of insulin on leptin transcription in adipocytes.

Authors:  Omar Mohtar; Cafer Ozdemir; Debasish Roy; Dharti Shantaram; Andrew Emili; Konstantin V Kandror
Journal:  J Biol Chem       Date:  2019-03-07       Impact factor: 5.157

8.  mTOR inhibitors for treatment of low-risk prostate cancer.

Authors:  Michael A Liss; Lanette Rickborn; John DiGiovanni; Dean Bacich; Linda A DeGraffenried; Manish Parihar; Ian M Thompson; Zelton Dave Sharp
Journal:  Med Hypotheses       Date:  2018-06-05       Impact factor: 1.538

9.  4E-BPs Control Fat Storage by Regulating the Expression of Egr1 and ATGL.

Authors:  Maneet Singh; Yu-Kyong Shin; Xiaoqing Yang; Brad Zehr; Partha Chakrabarti; Konstantin V Kandror
Journal:  J Biol Chem       Date:  2015-03-26       Impact factor: 5.157

10.  Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.

Authors:  Qingming Dong; Gipsy Majumdar; Robert N O'Meally; Robert N Cole; Marshall B Elam; Rajendra Raghow
Journal:  Mol Cell Biochem       Date:  2019-09-20       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.